{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T07:59:33Z","timestamp":1759564773712,"version":"3.28.0"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,8]],"date-time":"2025-06-08T00:00:00Z","timestamp":1749340800000},"content-version":"am","delay-in-days":311,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.lfs.2024.122776","type":"journal-article","created":{"date-parts":[[2024,6,7]],"date-time":"2024-06-07T16:53:39Z","timestamp":1717779219000},"page":"122776","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Intracerebroventricular 2-hydroxypropyl-\u03b3-cyclodextrin alleviates hepatic manifestations without distributing to the liver in a murine model of Niemann\u2013Pick disease type C"],"prefix":"10.1016","volume":"350","author":[{"given":"Yusei","family":"Yamada","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoichi","family":"Ishitsuka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Madoka","family":"Fukaura-Nishizawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuya","family":"Kawata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Ishii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aina","family":"Shirakawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taichi","family":"Sakai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mayuko","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuki","family":"Kondo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toru","family":"Takeo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naomi","family":"Nakagata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiichi","family":"Motoyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taishi","family":"Higashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidetoshi","family":"Arima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahiro","family":"Seki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuki","family":"Kurauchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Katsuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsumi","family":"Higaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryuji","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muneaki","family":"Matsuo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takumi","family":"Era","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsumi","family":"Irie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.lfs.2024.122776_bb0005","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1126\/science.277.5323.228","article-title":"Niemann-Pick C1 disease gene: homology to mediators of cholesterol homeostasis","volume":"277","author":"Carstea","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.lfs.2024.122776_bb0010","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.1126\/science.290.5500.2298","article-title":"Identification of HE1 as the second gene of Niemann-Pick C disease","volume":"290","author":"Naureckiene","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.lfs.2024.122776_bb0015","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/j.cell.2009.03.049","article-title":"Structure of N-terminal domain of NPC1 reveals distinct subdomains for binding and transfer of cholesterol","volume":"137","author":"Kwon","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.lfs.2024.122776_bb0020","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.ymgme.2019.02.004","article-title":"Evaluation of age of death in Niemann-Pick disease, type C: utility of disease support group websites to understand natural history","volume":"126","author":"Bianconi","year":"2019","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.lfs.2024.122776_bb0025","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1021\/cr970025p","article-title":"Cyclodextrin drug carrier systems","volume":"98","author":"Uekama","year":"1998","journal-title":"Chem. Rev."},{"key":"10.1016\/j.lfs.2024.122776_bb0030","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.ymgmr.2014.08.004","article-title":"Effects of intracerebroventricular administration of 2-hydroxypropyl-\u03b2-cyclodextrin in a patient with Niemann-Pick type C disease","volume":"1","author":"Matsuo","year":"2014","journal-title":"Mol. Genet. Metab. Rep."},{"key":"10.1016\/j.lfs.2024.122776_bb0035","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.ymgme.2012.11.005","article-title":"Effects of cyclodextrin in two patients with Niemann-Pick type C disease","volume":"108","author":"Matsuo","year":"2013","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.lfs.2024.122776_bb0040","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1007\/s10072-017-2833-9","article-title":"Early experience with compassionate use of 2 hydroxypropyl-beta-cyclodextrin for Niemann-Pick type C disease: review of initial published cases","volume":"38","author":"Meg\u00edas-Vericat","year":"2017","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.lfs.2024.122776_bb0045","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1016\/S0140-6736(17)31465-4","article-title":"Intrathecal 2-hydroxypropyl-\u03b2-cyclodextrin decreases neurological disease progression in Niemann-Pick disease, type C1: a non-randomised, open-label, phase 1-2 trial","volume":"390","author":"Ory","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.lfs.2024.122776_bb0050","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1248\/bpb.b14-00726","article-title":"Efficacy of 2-hydroxypropyl-\u03b2-cyclodextrin in Niemann-Pick disease type C model mice and its pharmacokinetic analysis in a patient with the disease","volume":"38","author":"Tanaka","year":"2015","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.lfs.2024.122776_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2022.114617","article-title":"Cyclodextrins applied to the treatment of lysosomal storage disorders","volume":"191","author":"Ishitsuka","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.lfs.2024.122776_bb0060","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21030898","article-title":"Differential effects of 2-hydroxypropyl-cyclodextrins on lipid accumulation in Npc1-null cells","volume":"21","author":"Hoque","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.lfs.2024.122776_bb0065","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1002\/stem.1917","article-title":"HPGCD outperforms HPBCD as a potential treatment for Niemann-Pick disease type C during disease modeling with iPS cells","volume":"33","author":"Soga","year":"2015","journal-title":"Stem Cells"},{"key":"10.1016\/j.lfs.2024.122776_bb0070","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1111\/bph.15464","article-title":"Differential mode of cholesterol inclusion with 2-hydroxypropyl-cyclodextrins increases safety margin in treatment of Niemann-Pick disease type C","volume":"178","author":"Yamada","year":"2021","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.lfs.2024.122776_bb0075","doi-asserted-by":"crossref","first-page":"802","DOI":"10.3390\/nano9050802","article-title":"In vivo efficacy and safety evaluation of lactosyl-\u03b2-cyclodextrin as a therapeutic agent for hepatomegaly in Niemann-Pick type C disease","volume":"9","author":"Maeda","year":"2019","journal-title":"Nanomaterials"},{"key":"10.1016\/j.lfs.2024.122776_bb0080","doi-asserted-by":"crossref","unstructured":"Yamada, Y., Fukaura-Nishizawa, M., Nishiyama, A., Ishii, A., Kawata, T., Shirakawa, A., Tanaka, M., Kondo, Y., Takeo, T., Nakagata, N., Miwa, T., Takeda, H., Orita, Y., Motoyama, K., Higashi, T., Arima, H., Seki, T., Kurauchi, Y., Katsuki, H., Higaki, K., Minami, K., Yoshikawa, N., Ikeda, R., Matsuo, M., Irie, T., Ishitsuka, Y., 2023. Different solubilizing ability of cyclodextrin derivatives for cholesterol in Niemann\u2013Pick disease type C treatment. Clin. Transl. Med. 13, e1350. doi:https:\/\/doi.org\/10.1002\/ctm2.1350.","DOI":"10.1002\/ctm2.1350"},{"key":"10.1016\/j.lfs.2024.122776_bb0085","doi-asserted-by":"crossref","unstructured":"Yamada, Y., Miwa, T., Nakashima, M., Shirakawa, A., Ishii, A., Namba, N., Kondo, Y., Takeo, T., Nakagata, N., Motoyama, K., Higashi, T., Arima, H., Kurauchi, Y., Seki, T., Katsuki, H., Okada, Y., Ichikawa, A., Higaki, K., Hayashi, K., Minami, K., Yoshikawa, N., Ikeda, R., Ishikawa, Y., Kajii, T., Tachii, K., Takeda, H., Orita, Y., Matsuo, M., Irie, T., Ishitsuka, Y., 2022. Fine-tuned cholesterol solubilizer, mono-6-O-\u03b1-D-maltosyl-\u03b3-cyclodextrin, ameliorates experimental Niemann\u2013Pick disease type C without hearing loss. Biomed. Pharmacother. 155, 113698. doi:https:\/\/doi.org\/10.1016\/j.biopha.2022.113698.","DOI":"10.1016\/j.biopha.2022.113698"},{"key":"10.1016\/j.lfs.2024.122776_bb0090","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.3390\/ijms20051152","article-title":"In vitro and in vivo evaluation of 6-O-\u03b1-Maltosyl-\u03b2-Cyclodextrin as a potential therapeutic agent against Niemann-Pick disease type C","volume":"20","author":"Yasmin","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.lfs.2024.122776_bb0095","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1093\/oxfordjournals.jbchem.a002932","article-title":"Isolation of NPC1-deficient Chinese hamster ovary cell mutants by gene trap mutagenesis","volume":"129","author":"Higaki","year":"2001","journal-title":"J. Biochem."},{"key":"10.1016\/j.lfs.2024.122776_bb0100","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.ymgme.2016.04.014","article-title":"In vitro evaluation of 2-hydroxyalkylated \u03b2-cyclodextrins as potential therapeutic agents for Niemann-Pick type C disease","volume":"118","author":"Kondo","year":"2016","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.lfs.2024.122776_bb0105","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1126\/science.277.5323.232","article-title":"Murine model of Niemann-Pick C disease: mutation in a cholesterol homeostasis gene","volume":"277","author":"Loftus","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.lfs.2024.122776_bb0110","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1002\/hep.20868","article-title":"Cholesterol accumulation and liver cell death in mice with Niemann-Pick type C disease","volume":"42","author":"Beltroy","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.lfs.2024.122776_bb0115","doi-asserted-by":"crossref","unstructured":"German, D.C., Quintero, E.M., Liang, C.-L., Xie, C., Dietschy, J.M., 2001. Degeneration of neurons and glia in the Niemann\u2013Pick C mouse is unrelated to the low-density lipoprotein receptor. Neuroscience 105, 999\u20131005. doi:https:\/\/doi.org\/10.1016\/S0306-4522(01)00230-5.","DOI":"10.1016\/S0306-4522(01)00230-5"},{"key":"10.1016\/j.lfs.2024.122776_bb0120","doi-asserted-by":"crossref","unstructured":"Maue, R.A., Burgess, R.W., Wang, B., Wooley, C.M., Seburn, K.L., Vanier, M.T., Rogers, M.A., Chang, C.C., Chang, T.-Y., Harris, B.T., Graber, D.J., Penatti, C.A.A., Porter, D.M., Szwergold, B.S., Henderson, L.P., Totenhagen, J.W., Trouard, T.P., Borbon, I.A., Erickson, R.P., 2012. A novel mouse model of Niemann\u2013Pick type C disease carrying a D1005G-Npc1 mutation comparable to commonly observed human mutations. Hum. Mol. Genet. 21, 730\u2013750. doi:https:\/\/doi.org\/10.1093\/hmg\/ddr505.","DOI":"10.1093\/hmg\/ddr505"},{"key":"10.1016\/j.lfs.2024.122776_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2020.165875","article-title":"Finding pathogenic commonalities between Niemann-Pick type C and other lysosomal storage disorders: opportunities for shared therapeutic interventions","volume":"1866","author":"Ya\u00f1ez","year":"2020","journal-title":"Biochim. Biophys. Acta Mol. basis Dis."},{"key":"10.1016\/j.lfs.2024.122776_bb0130","doi-asserted-by":"crossref","unstructured":"Fukaura, M., Ishitsuka, Y., Shirakawa, S., Ushihama, N., Yamada, Y., Kondo, Y., Takeo, T., Nakagata, N., Motoyama, K., Higashi, T., Arima, H., Kurauchi, Y., Seki, T., Katsuki, H., Higaki, K., Matsuo, M., Irie, T., 2021. Intracerebroventricular Treatment with 2-Hydroxypropyl-\u03b2-Cyclodextrin Decreased Cerebellar and Hepatic Glycoprotein Nonmetastatic Melanoma Protein B (GPNMB) Expression in Niemann\u2013Pick Disease Type C Model Mice. Int. J. Mol. Sci. 22, 452. doi:https:\/\/doi.org\/10.3390\/ijms22010452.","DOI":"10.3390\/ijms22010452"},{"key":"10.1016\/j.lfs.2024.122776_bb0135","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0084856","article-title":"Fluorescently labeled methyl-beta-cyclodextrin enters intestinal epithelial Caco-2 cells by fluid-phase endocytosis","volume":"9","author":"Fenyvesi","year":"2014","journal-title":"PloS One"},{"key":"10.1016\/j.lfs.2024.122776_bb0140","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.carres.2017.11.003","article-title":"Role of 6-O-\u03b1-maltosyl-\u03b2-cyclodextrin in lysosomal cholesterol deprivation in Npc1-deficient Chinese hamster ovary cells","volume":"455","author":"Okada","year":"2018","journal-title":"Carbohydr. Res."},{"key":"10.1016\/j.lfs.2024.122776_bb0145","doi-asserted-by":"crossref","first-page":"5477","DOI":"10.1073\/pnas.0914309107","article-title":"Endocytosis of beta-cyclodextrins is responsible for cholesterol reduction in Niemann-Pick type C mutant cells","volume":"107","author":"Rosenbaum","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.lfs.2024.122776_bb0150","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1172\/JCI119223","article-title":"Cyclodextrins as catalysts for the removal of cholesterol from macrophage foam cells","volume":"99","author":"Atger","year":"1997","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.lfs.2024.122776_bb0155","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1002\/jps.2600810610","article-title":"Hydroxypropylcyclodextrins in parenteral use. II: effects on transport and disposition of lipids in rabbit and humans","volume":"81","author":"Irie","year":"1992","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.lfs.2024.122776_bb0160","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1111\/j.1365-2249.2008.03779.x","article-title":"Novel mechanism of U18666A-induced tumour necrosis factor-\u03b1 production in RAW 264\u00b77 macrophage cells","volume":"155","author":"Iftakhar-E-Khuda","year":"2009","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.lfs.2024.122776_bb0165","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1002\/hep.22327","article-title":"In vivo antisense oligonucleotide reduction of NPC1 expression as a novel mouse model for Niemann Pick type C- associated liver disease","volume":"47","author":"Rimkunas","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.lfs.2024.122776_bb0170","article-title":"Long-term administration of intravenous Trappsol\u00ae CycloTM (HP-\u03b2-CD) results in clinical benefits and stabilization or slowing of disease progression in patients with Niemann-Pick disease type C1: results of an international 48-week phase I\/II trial","volume":"36","author":"Sharma","year":"2023","journal-title":"Mol. Genet. Metab. Rep."},{"key":"10.1016\/j.lfs.2024.122776_bb0175","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1021\/js960213f","article-title":"Pharmaceutical applications of cyclodextrins. III. Toxicological issues and safety evaluation","volume":"86","author":"Irie","year":"1997","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.lfs.2024.122776_bb0180","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1177\/0192623307310945","article-title":"Cyclodextrins","volume":"36","author":"Stella","year":"2008","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.lfs.2024.122776_bb0185","doi-asserted-by":"crossref","first-page":"6231","DOI":"10.2174\/1381612823666171019164220","article-title":"2-Hydroxypropyl-\u03b2-cyclodextrins and the blood-brain barrier: considerations for Niemann-Pick disease type C1","volume":"23","author":"Calias","year":"2017","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.lfs.2024.122776_bb0190","doi-asserted-by":"crossref","first-page":"3783","DOI":"10.3390\/cells11233783","article-title":"Current perspectives of neuroendocrine regulation in liver fibrosis","volume":"11","author":"Li","year":"2022","journal-title":"Cells"}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320524003667?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320524003667?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,21]],"date-time":"2024-11-21T10:54:45Z","timestamp":1732186485000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320524003667"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":38,"alternative-id":["S0024320524003667"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2024.122776","relation":{},"ISSN":["0024-3205"],"issn-type":[{"type":"print","value":"0024-3205"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intracerebroventricular 2-hydroxypropyl-\u03b3-cyclodextrin alleviates hepatic manifestations without distributing to the liver in a murine model of Niemann\u2013Pick disease type C","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2024.122776","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"122776"}}